The Virus Filtration Market size is projected to reach US$ 6.14 Bn. at the end of the forecast period at a CAGR of 14%. The growth is coupled with the rising prevalence of chronic diseases including cancer, diabetes, and autoimmune disorders. According to the International Agency for Research on Cancer, around 14.1 million new cancer cases were diagnosed worldwide in 2017 and this number is projected to reach 21.7 million by 2022. Thus, there is a growing demand for therapeutic biologics for the treatment of such chronic diseases, which consequently propel the demand for virus filtration products for R&D and manufacturing applications. Compliance with drug development & production regulatory frameworks such as Current Good Manufacturing Practice (cGMP) regulations is another main driver expected to boost the Global Virus Filtration Market. Virus safety of these products is ensured by manufacturers through various quality control measures such as monitoring and quality check of raw materials, validation & implementation of efficient virus clearance technology, as well as validation of the final product for the absence of virus contamination. Thus, the demand for these products is very high for manufacturing and R&D practices. To know about the Research Methodology :- Request Free Sample Report North America virus filtration market dominated the overall sector and is expected to maintain its dominance during the study period. The well-established biotechnology and biopharmaceutical industry in the U.S. has spurred the demand for advanced viral clearance products for R&D and biologics production in this region. Europe was the second largest market due to high demand for innovative virus filtration products for research and biologics development & production. In addition, highly developed healthcare infrastructure and investment of a large amount of money in R&D, primarily in Germany, UK, and France are expected to drive the regional market. The consumables segment accounted for the largest share of the market in 2022 and is expected to showcase lucrative growth over the forecast period owing to the increased usage of these virus filtration products. The rising focus on the development of vaccines, protein therapeutics, blood products, cellular therapy products, gene therapy products, tissue products, and stem cell products is expected to boost the demand for consumables including reagents, kits, and membranes.Virus Filtration Market Scope: Inquire before buying
Virus Filtration Market
Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 2.45 Bn. Forecast Period 2023 to 2029 CAGR: 14% Market Size in 2029: US $ 6.14 Bn. Segments Covered: by Product Consumables Kits and reagents Others Instruments Filtration systems Chromatography systems Services By End-Use Biopharmaceutical & biotechnology companies Contract research organizations Medical devices companies Academic institutes & research laboratories by Application Biologicals Vaccines and therapeutics Blood and blood products Cellular and gene therapy products Tissue and tissue products Stem cell products Medical devices Water purification Air purification Virus Filtration Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key Players are:
1. Merck KGaA 2. General Electric Company 3. Thermo Fisher Scientific Inc. 4. Lonza Group Ltd. 5. Pall Corporation 6. Charles River Laboratories International, Inc. 7. Sigma-Aldrich Corporation 8. Sartorius AG 9. Asahi Kasei Medical Co., Ltd. 10.WuXi PharmaTech 11.Sartorius 12.Danaher 13.GE Healthcare 14.Clean Cells 15.QIAGEN 16.Agilent Technologies 17.Bio-Rad Laboratories, Inc. 18.Hoffmann-La Roche Ltd 19.Pfizer Inc. 20.Hospitech 21.CSL Behring 22.Illumina, Inc. 23.Eppendorf AG 24.PromoCell GmbH 25.HiMedia Laboratories Frequently Asked Questions: 1. Which region has the largest share in Virus Filtration Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Virus Filtration Market? Ans: The Global Virus Filtration Market is growing at a CAGR of 14% during forecasting period 2023-2029. 3. What is scope of the Global Virus Filtration market report? Ans: Global Virus Filtration Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Virus Filtration market? Ans: The important key players in the Global Virus Filtration Market are – Merck KGaA, General Electric Company, Thermo Fisher Scientific Inc., Lonza Group Ltd., Pall Corporation, Charles River Laboratories International, Inc., Sigma-Aldrich Corporation, Sartorius AG, Asahi Kasei Medical Co., Ltd., WuXi PharmaTech, Sartorius, Danaher, GE Healthcare, Clean Cells, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd, Pfizer Inc., Hospitech, CSL Behring, Illumina, Inc., Eppendorf AG, PromoCell GmbH, and HiMedia Laboratories 5. What is the study period of this market? Ans: The Global Virus Filtration Market is studied from 2022 to 2029.
Virus Filtration Market
Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global Virus Filtration Market overview 2.1.1. By Product 2.1.2. By End-Use 2.1.3. By Applications Chapter 3 Global Virus Filtration Market Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Increasing demand for biological products 3.2.1.2. Rising prevalence of chronic diseases 3.2.2. Market Restrains 3.2.2.1. Highly consolidated market 3.2.2.2. Stringent regulations for filtration product validation 3.3. Market share analysis 3.3.1. By Product 3.3.2. By End-Use 3.3.3. By Applications 3.4. Competitive analysis 3.4.1. Key strategic initiatives 3.4.2. Regional presence 3.4.3. Product overview 3.5. Porter’s analysis 3.6. PESTEL analysis Chapter 4 Virus Filtration Market, By Products 4.1. Key segment trends 4.2. Consumables 4.2.1. Market size, by region, 2022 - 2029 4.3. Kits and reagents 4.3.1. Market size, by region, 2022 - 2029 4.4. Others 4.4.1. Market size, by region, 2022 - 2029 4.5. Instruments 4.5.1. Market size, by region, 2022 - 2029 4.6. Filtration systems 4.6.1. Market size, by region, 2022 - 2029 4.7. Chromatography systems 4.7.1. Market size, by region, 2022 - 2029 4.8. Services 4.8.1. Market size, by region, 2022 - 2029 4.8.2. Key Trends in Global Virus Filtration Market Chapter 5 Virus Filtration Market, By Applications 5.1. Key segment trends 5.2. Biologicals 5.2.1. Market size, by region, 2022 - 2029 5.3. Vaccines and therapeutics 5.3.1. Market size, by region, 2022 - 2029 5.4. Blood and blood products 5.4.1. Market size, by region, 2022 - 2029 5.5. Cellular and gene therapy products 5.5.1. Market size, by region, 2022 - 2029 5.6. Tissue and tissue products 5.6.1. Market size, by region, 2022 - 2029 5.7. Stem cell products 5.7.1. Market size, by region, 2022 - 2029 5.8. Medical devices 5.8.1. Market size, by region, 2022 - 2029 5.9. Water purification 5.9.1. Market size, by region, 2022 - 2029 5.10. Air purification 5.10.1. Market size, by region, 2022 - 2029 Chapter 6 Virus Filtration Market, By End-Use 6.1. Key segment trends 6.2. Biopharmaceutical & biotechnology companies 6.2.1. Market size, by region, 2022 - 2029 6.3. Contract research organizations 6.3.1. Market size, by region, 2022 - 2029 6.4. Medical devices companies 6.4.1. Market size, by region, 2022 - 2029 6.5. Academic institutes & research laboratories 6.5.1. Market size, by region, 2022 - 2029 Chapter 7 Virus Filtration Market, By Region 7.1. Key regional trends 7.2. North America 7.2.1. Market size, by country, 2022 - 2029 7.2.2. Market size, by end-use, 2022 - 2029 7.2.3. Market size, by products, 2022 - 2029 7.2.4. Market size, by applications, 2022 - 2029 7.2.5. U.S. 7.2.5.1. Market size, by end-use, 2022 - 2029 7.2.5.2. Market size, by products, 2022 - 2029 7.2.5.3. Market size, by applications, 2022 - 2029 7.2.6. Canada 7.2.6.1. Market size, by end-use, 2022 - 2029 7.2.6.2. Market size, by products, 2022 - 2029 7.2.6.3. Market size, by applications, 2022 - 2029 7.3. Europe 7.3.1. Market size, by country, 2022 - 2029 7.3.2. Market size, by end-use, 2022 - 2029 7.3.3. Market size, by products, 2022 - 2029 7.3.4. Market size, by applications, 2022 - 2029 7.3.5. Germany 7.3.5.1. Market size, by end-use, 2022 - 2029 7.3.5.2. Market size, by products, 2022 - 2029 7.3.5.3. Market size, by applications, 2022 - 2029 7.3.6. UK 7.3.6.1. Market size, by end-use, 2022 - 2029 7.3.6.2. Market size, by products, 2022 - 2029 7.3.6.3. Market size, by applications, 2022 - 2029 7.3.7. France 7.3.7.1. Market size, by end-use, 2022 - 2029 7.3.7.2. Market size, by products, 2022 - 2029 7.3.7.3. Market size, by applications, 2022 - 2029 7.3.8. Spain 7.3.8.1. Market size, by end-use, 2022 - 2029 7.3.8.2. Market size, by products, 2022 - 2029 7.3.8.3. Market size, by applications, 2022 - 2029 7.3.9. Italy 7.3.9.1. Market size, by end-use, 2022 - 2029 7.3.9.2. Market size, by products, 2022 - 2029 7.3.9.3. Market size, by applications, 2022 - 2029 7.4. Asia Pacific 7.4.1. Market size, by country, 2022 - 2029 7.4.2. Market size, by end-use, 2022 - 2029 7.4.3. Market size, by products, 2022 - 2029 7.4.4. Market size, by applications, 2022 - 2029 7.4.5. India 7.4.5.1. Market size, by end-use, 2022 - 2029 7.4.5.2. Market size, by products, 2022 - 2029 7.4.5.3. Market size, by applications, 2022 - 2029 7.4.6. China 7.4.6.1. Market size, by end-use, 2022 - 2029 7.4.6.2. Market size, by products, 2022 - 2029 7.4.6.3. Market size, by applications, 2022 - 2029 7.4.7. Japan 7.4.7.1. Market size, by end-use, 2022 - 2029 7.4.7.2. Market size, by products, 2022 - 2029 7.4.7.3. Market size, by applications, 2022 - 2029 7.4.8. Australia 7.4.8.1. Market size, by end-use, 2022 - 2029 7.4.8.2. Market size, by products, 2022 - 2029 7.4.8.3. Market size, by applications, 2022 - 2029 7.5. Latin America 7.5.1. Market size, by country, 2022 - 2029 7.5.2. Market size, by end-use, 2022 - 2029 7.5.3. Market size, by products, 2022 - 2029 7.5.4. Market size, by applications, 2022 - 2029 7.5.5. Argentina 7.5.5.1. Market size, by end-use, 2022 - 2029 7.5.5.2. Market size, by products, 2022 - 2029 7.5.5.3. Market size, by applications, 2022 - 2029 7.5.6. Brazil 7.5.6.1. Market size, by end-use, 2022 - 2029 7.5.6.2. Market size, by products, 2022 - 2029 7.5.6.3. Market size, by applications, 2022 - 2029 7.5.7. Mexico 7.5.7.1. Market size, by end-use, 2022 - 2029 7.5.7.2. Market size, by products, 2022 - 2029 7.5.7.3. Market size, by applications, 2022 - 2029 7.6. Middle East and Africa 7.6.1. Market size, by country, 2022 - 2029 7.6.2. Market size, by end-use, 2022 - 2029 7.6.3. Market size, by products, 2022 - 2029 7.6.4. Market size, by applications, 2022 - 2029 7.6.5. South Africa 7.6.5.1. Market size, by end-use, 2022 - 2029 7.6.5.2. Market size, by products, 2022 - 2029 7.6.5.3. Market size, by applications, 2022 - 2029 7.6.6. Saudi Arabia 7.6.6.1. Market size, by end-use, 2022 - 2029 7.6.6.2. Market size, by products, 2022 - 2029 7.6.6.3. Market size, by applications, 2022 - 2029 Chapter 8 Consolidations 8.1. Mergers and Acquisitions 8.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 8.3. Patent Analysis 8.4. Key players 8.4.1. Merck KGaA 8.4.1.1. Company overview 8.4.1.2. Key financials 8.4.1.3. Product landscape 8.4.1.4. Strategic initiatives 8.4.1.5. SWOT analysis 8.4.2. General Electric Company 8.4.2.1. Company overview 8.4.2.2. Key financials 8.4.2.3. Product landscape 8.4.2.4. Strategic initiatives 8.4.2.5. SWOT analysis 8.4.3. Thermo Fisher Scientific Inc. 8.4.3.1. Company overview 8.4.3.2. Key financials 8.4.3.3. Product landscape 8.4.3.4. Strategic initiatives 8.4.3.5. SWOT analysis 8.4.4. Lonza Group Ltd. 8.4.4.1. Company overview 8.4.4.2. Key financials 8.4.4.3. Product landscape 8.4.4.4. Strategic initiatives 8.4.4.5. SWOT analysis 8.4.5. Pall Corporation 8.4.5.1. Company overview 8.4.5.2. Key financials 8.4.5.3. Product landscape 8.4.5.4. Strategic initiatives 8.4.5.5. SWOT analysis 8.4.6. Charles River Laboratories International, Inc. 8.4.6.1. Company overview 8.4.6.2. Key financials 8.4.6.3. Product landscape 8.4.6.4. Strategic initiatives 8.4.6.5. SWOT analysis 8.4.7. Sigma-Aldrich Corporation 8.4.7.1. Company overview 8.4.7.2. Key financials 8.4.7.3. Product landscape 8.4.7.4. Strategic initiatives 8.4.7.5. SWOT analysis 8.4.8. Sartorius AG 8.4.8.1. Company overview 8.4.8.2. Key financials 8.4.8.3. Product landscape 8.4.8.4. Strategic initiatives 8.4.8.5. SWOT analysis 8.4.9. Asahi Kasei Medical Co., Ltd. 8.4.9.1. Company overview 8.4.9.2. Key financials 8.4.9.3. Product landscape 8.4.9.4. Strategic initiatives 8.4.9.5. SWOT analysis 8.4.10. WuXi PharmaTech 8.4.10.1. Company overview 8.4.10.2. Key financials 8.4.10.3. Product landscape 8.4.10.4. Strategic initiatives 8.4.10.5. SWOT analysis 8.4.11. Sartorius 8.4.11.1. Company overview 8.4.11.2. Key financials 8.4.11.3. Product landscape 8.4.11.4. Strategic initiatives 8.4.11.5. SWOT analysis 8.4.12. Danaher 8.4.12.1. Company overview 8.4.12.2. Key financials 8.4.12.3. Product landscape 8.4.12.4. Strategic initiatives 8.4.12.5. SWOT analysis 8.4.13. GE Healthcare 8.4.13.1. Company overview 8.4.13.2. Key financials 8.4.13.3. Product landscape 8.4.13.4. Strategic initiatives 8.4.13.5. SWOT analysis 8.4.14. Clean Cells 8.4.14.1. Company overview 8.4.14.2. Key financials 8.4.14.3. Product landscape 8.4.14.4. Strategic initiatives 8.4.14.5. SWOT analysis 8.4.15. QIAGEN 8.4.15.1. Company overview 8.4.15.2. Key financials 8.4.15.3. Product landscape 8.4.15.4. Strategic initiatives 8.4.15.5. SWOT analysis 8.4.16. Agilent Technologies 8.4.16.1. Company overview 8.4.16.2. Key financials 8.4.16.3. Product landscape 8.4.16.4. Strategic initiatives 8.4.16.5. SWOT analysis 8.4.17. Bio-Rad Laboratories, Inc. 8.4.17.1. Company overview 8.4.17.2. Key financials 8.4.17.3. Product landscape 8.4.17.4. Strategic initiatives 8.4.17.5. SWOT analysis 8.4.18. Hoffmann-La Roche Ltd 8.4.18.1. Company overview 8.4.18.2. Key financials 8.4.18.3. Product landscape 8.4.18.4. Strategic initiatives 8.4.18.5. SWOT analysis 8.4.19. Pfizer Inc. 8.4.19.1. Company overview 8.4.19.2. Key financials 8.4.19.3. Product landscape 8.4.19.4. Strategic initiatives 8.4.19.5. SWOT analysis 8.4.20. Hospitech 8.4.20.1. Company overview 8.4.20.2. Key financials 8.4.20.3. Product landscape 8.4.20.4. Strategic initiatives 8.4.20.5. SWOT analysis 8.4.21. CSL Behring 8.4.21.1. Company overview 8.4.21.2. Key financials 8.4.21.3. Product landscape 8.4.21.4. Strategic initiatives 8.4.21.5. SWOT analysis 8.4.22. Illumina, Inc. 8.4.22.1. Company overview 8.4.22.2. Key financials 8.4.22.3. Product landscape 8.4.22.4. Strategic initiatives 8.4.22.5. SWOT analysis 8.4.23. Eppendorf AG 8.4.23.1. Company overview 8.4.23.2. Key financials 8.4.23.3. Product landscape 8.4.23.4. Strategic initiatives 8.4.23.5. SWOT analysis 8.4.24. PromoCell GmbH 8.4.24.1. Company overview 8.4.24.2. Key financials 8.4.24.3. Product landscape 8.4.24.4. Strategic initiatives 8.4.24.5. SWOT analysis 8.4.25. HiMedia Laboratories 8.4.25.1. Company overview 8.4.25.2. Key financials 8.4.25.3. Product landscape 8.4.25.4. Strategic initiatives 8.4.25.5. SWOT analysis